Fahima Hashem
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 13
- Drug Solubulity and Delivery Systems 12
- Advancements in Transdermal Drug Delivery 4
-
- Lipid Membrane Structure and Behavior 3
- Co-authors
- Mohamed Nasr (10 shared papers)Dalia S. Shaker (3 shared papers)Aliaa Ismail (2 shared papers)Mohamed K. Ghorab (1 shared paper)Majid Mohammad Al-Sawahli (3 shared papers)Osama A. A. Ahmed (2 shared papers)A. H. Ghanem (1 shared paper)Kevin S. Warner (1 shared paper)
- Journals
- AAPS PharmSciTech (4 papers)Pharmaceutical Development and Technology (2 papers)International Journal of Nanomedicine (2 papers)Indian Journal of Pharmaceutical Education and Research (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- EgyptSaudi ArabiaIndonesia
In The Last Decade
Fahima Hashem
24 papers receiving 381 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 211
- Biomaterials 85
- Drug Discovery 1
- Dermatology 42
- Molecular Medicine 19
Countries citing papers authored by Fahima Hashem
This map shows the geographic impact of Fahima Hashem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahima Hashem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahima Hashem more than expected).
Fields of papers citing papers by Fahima Hashem
This network shows the impact of papers produced by Fahima Hashem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahima Hashem. The network helps show where Fahima Hashem may publish in the future.
Co-authors
The 17 scholars most cited alongside Fahima Hashem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 105 | |
| 2 | 2015 | 41 | |
| 3 | 2018 | 31 | |
| 4 | 2003 | 31 | |
| 5 | 2013 | 31 | |
| 6 | 2023 | 23 | |
| 7 | 2018 | 22 | |
| 8 | 2011 | 18 | |
| 9 | 2015 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2020 | 12 | |
| 12 | 2015 | 9 | |
| 13 | 2014 | 8 | |
| 14 | 2011 | 8 | |
| 15 | 2013 | 7 | |
| 16 | 2013 | 4 | |
| 17 | 1991 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2012 | 2 |
About Fahima Hashem
Fahima Hashem is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Organic Chemistry and Pharmacology, having authored 24 papers that have together received 394 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (12 papers), Nanoparticle-Based Drug Delivery (5 papers), Advancements in Transdermal Drug Delivery (4 papers), Lipid Membrane Structure and Behavior (3 papers), Pharmaceutical studies and practices (3 papers), Surfactants and Colloidal Systems (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Pharmaceutical Science (211 citations), Biomaterials (85 citations), Drug Discovery (1 citation), Dermatology (42 citations) and Molecular Medicine (19 citations). Fahima Hashem has collaborated with scholars based in Egypt, Saudi Arabia and Indonesia. Frequent co-authors include Mohamed Nasr, Dalia S. Shaker, Aliaa Ismail, Mohamed K. Ghorab, Majid Mohammad Al-Sawahli, Osama A. A. Ahmed, A. H. Ghanem, Kevin S. Warner, William I. Higuchi and S. Kevin Li. Their work appears in journals such as AAPS PharmSciTech, Pharmaceutical Development and Technology, International Journal of Nanomedicine, Indian Journal of Pharmaceutical Education and Research and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.